GLOBAL HEALTH | GLOBAL PARTNERSHIPS | GLOBAL IMPACT

HIP ATTACK: Lancet and ORS

Among patients with a hip fracture, accelerated surgery did not significantly lower the risk of mortality or a composite of major complications compared with standard care – that was the finding of HIP ATTACK, the five-year, international RCT led by PHRI’s PJ Devereaux. The trial was conducted at 69 hospitals in 17 countries with patients with a hip fracture that required surgery, aged 45 years or older.

The findings were published on Feb. 9, 2020 in The Lancet, the same day that Dr. Devereaux presented the findings at the Orthopaedic Research Society (ORS) Clinical Research Forum in Phoenix, AZ.

In these interviews at OE OrthoPod, Dr. Devereaux discusses the trial’s insights, and Flavia Borges, project officer for HIP ATTACK, discusses the methods behind the trial.

More recently, CHCH Hamilton, Morning Live show, conducted a TV interview with Dr. Devereaux about HIP-ATTACK.